Pharmaceutical Analysis & Statistics, February 2015 (p30)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

871-900 of about 21 000 reports

Purchase Reports From Reputable Market Research Publishers

Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Pathology
  • Countries : United States
Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Tourette Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Tourette Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Tourette Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Type I Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Type I Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Type I Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Varicella Zoster (HHV-3) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Varicella Zoster (HHV-3) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Varicella Zoster (HHV-3) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Drug and Medication
  • Countries : United States
Vasculitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Vasculitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Vasculitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Venous (Vein) Thrombosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Venous (Vein) Thrombosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Venous (Vein) Thrombosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Venous Thromboembolism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Venous Thromboembolism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Venous Thromboembolism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Ventilator Associated Pneumonia (VAP)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Ventilator Associated Pneumonia (VAP)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Ventilator Associated Pneumonia (VAP)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Ventricular Fibrillation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Ventricular Fibrillation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Ventricular Fibrillation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Von Willebrand Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Wet (Neovascular / Exudative) Macular Degeneration-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Wet (Neovascular / Exudative) Macular Degeneration-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Wet (Neovascular / Exudative) Macular Degeneration-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline ...

  • Industries : Drug and Medication
  • Countries : United States
Wilms' Tumor (Nephroblastoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Wilms' Tumor (Nephroblastoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Wilms' Tumor (Nephroblastoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Wolff-Parkinson-White Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Wolff-Parkinson-White Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Wolff-Parkinson-White Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Yersinia Pestis Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Yersinia Pestis Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Yersinia Pestis Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Japan Pharma  Outlook 2015: 2015 -Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

Japan Pharma Outlook 2015: 2015 -Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

  • $ 2 000
  • Industry report
  • January 2015
  • by MP Advisors

The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating ...

  • Industries : Pathology
  • Countries : Japan
Sri Lanka Pharma Market  Outlook 2015: More beyond Importers & Distributors

Sri Lanka Pharma Market Outlook 2015: More beyond Importers & Distributors

  • $ 2 000
  • Industry report
  • January 2015
  • by MP Advisors

With the recent development, Sri Lanka's aim of developing a pharma industry should be to penetrate the global market since the internal market is not sufficient for any big firm to operate at optimum ...

  • Industries : Drug and Medication
  • Countries : Sri Lanka
Global Pharma US & EU Outlook 2015  : First -In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies

Global Pharma US & EU Outlook 2015 : First -In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies

  • $ 2 000
  • Industry report
  • January 2015
  • by MP Advisors

Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition. In the recent years several ...

  • Industries : Pathology
  • Countries : United States, World
Mature Biotech  Outlook 2015: New Therapy Ventures Pave the Way for Success

Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success

  • $ 2 000
  • Industry report
  • January 2015
  • by MP Advisors

All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a positive return and hence increased the interest of biotech investors. These companies ...

  • Industries : Pathology
World Pathology: Tardive Dyskinesia – Pipeline Review, H1 2012

World Pathology: Tardive Dyskinesia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

This report provides information on the therapeutic development for Tardive Dyskinesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : World
Thromboembolism - Pipeline Review, H1 2015

Thromboembolism - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Thromboembolism - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Thromboembolism - Pipeline Review, H1 2015', provides an overview of the Thromboembolism's therapeutic pipeline. This report ...

  • Industries : Drug Discovery and Development
  • Countries : Japan, World
Status Epilepticus - Pipeline Review, H1 2015

Status Epilepticus - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Status Epilepticus - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Status Epilepticus - Pipeline Review, H1 2015', provides an overview of the Status Epilepticus's therapeutic pipeline. ...

  • Industries : Drug Discovery and Development
  • Countries : World
Pulmonary Fibrosis - Pipeline Review, H1 2015

Pulmonary Fibrosis - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Pulmonary Fibrosis - Pipeline Review, H1 2015', provides an overview of the Pulmonary Fibrosis's therapeutic pipeline. ...

  • Industries : Drug and Medication
Premenstrual Syndrome - Pipeline Review, H1 2015

Premenstrual Syndrome - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Premenstrual Syndrome - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Premenstrual Syndrome - Pipeline Review, H1 2015', provides an overview of the Premenstrual Syndrome's therapeutic ...

  • Industries : Drug Discovery and Development
  • Countries : World
Kaposi%s Sarcoma - Pipeline Review, H1 2015

Kaposi%s Sarcoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Kaposi's Sarcoma - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Kaposi's Sarcoma - Pipeline Review, H1 2015', provides an overview of the Kaposi's Sarcoma's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015', provides an ...

  • Industries : Pathology
  • Countries : World
Trauma - Pipeline Review, H1 2015

Trauma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Trauma - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Trauma - Pipeline Review, H1 2015', provides an overview of the Trauma's therapeutic pipeline. This report provides comprehensive ...

  • Industries : Drug Discovery and Development
  • Countries : World
Biliary Cirrhosis - Pipeline Review, H1 2015

Biliary Cirrhosis - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Biliary Cirrhosis - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Biliary Cirrhosis - Pipeline Review, H1 2015', provides an overview of the Biliary Cirrhosis's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World
About 50 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • February 2015
    7 pages
  • Pathology  

    Obesity  

  • United Kingdom  

View report >

About 500 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.